Www.bit.bio

The days are getting longer and hotter the further we move into summer, and the warm weather and bright sunshine are definitely welcomed by most.

The pharmaceutical industry is seeking new ways to accelerate the drug development process, to generate both time and cost savings. How is nuclear magnetic resonance spectroscopy helping to improve the drug development sector?

Flow cytometry is a powerful technology in the emerging cell and gene therapies (CGT) field and plays a significant role in various stages in the adoptive cell therapies, but what are its advantages and limitations?

How are digital innovations such as artificial intelligence (AI) and machine learning (ML) helping to improve drug research and development?

www.iptonline.com

Using cloud computing in drug discovery and manufacturing has become increasingly popular over the past few years, however myths around the system still linger. What are these myths, and how can companies overcome them to feel more confident about going digital?

When 450 global pharma leaders were asked about what would make the biggest impact on the success of their digital products and strategies, ‘a shift to a consumer-first mindset’ was the top priority cited (42%). But, what does this really mean, and how can pharma teams achieve it?

www.flypharmaeurope.com

What is AI? As it is a relatively new field, we’re now beginning to see particular types show up in the pharma sector, bringing with it huge promises. However, what is ultimately realistic for our industry and for patients?

IPT sits down with Ronen Vengosh of Egnyte to discuss the emergence of cloud software in biotech companies, and how its integration will help further drug development and clinical trial management through data protection and sharing

The very phrase ‘data quality governance’ carries so much weight, especially in life sciences where data has to be right and consistent across all functions and with global health authorities. Yet achieving data quality governance doesn’t need to involve large internal and consulting teams with complex frameworks, long timelines and unwieldy success parameters – it can be a lot simpler

www.pharmafocus.com

For different binder-diluent ratios on the tablet mechanical strength, a proposed scale could serve as a ‘guiding torch’ for various formulators while designing preclinical or early phase formulations

www.samedanltd.com

High-titre CLD platform is an effective tool to overcome a number of challenges when developing a cell line. What are the challenges associated with developing a high-titre CLD platform and how can utilising novel technologies help overcome them?

Nanodrug carriers have gained increased attention in the pharma industry since they were used in the fight against COVID-19. What are they, and how can regulations improve the manufacture of them?

What are the differences and key design features which characterise successful tablet press performance in a continuous manufacturing setting?

IPT talks to Richard Stedman of ACG Engineering about the rise of connected and digitalised machines, and how these will improve pharmaceutical manufacturing in the future

Whether lab managers are enthusiastic or apprehensive, AI is coming to the lab. The key to building this advantage is not in the technology, but the approach. Successful adoption of AI requires a genuine, long-term commitment. IPT spoke to Bob Voelkner at LabVantage Solutions about the implications of AI for pharma, what it takes to succeed with this new technology and his five recommended steps for getting started

LabVantage Solutions’ Pharmaceutical LIMS is Engine for Digital Transformations

Healthcare and scientific facilities are critical for the health of the global population. During the COVID-19 pandemic, scientific facilities helped to deliver life-saving vaccines, re-emphasising their importance in achieving other scientific milestones in the coming decades

Pharmatech Events between June and September 2023.

Londonbiotechshow.com

Natoli.com